Investors
Investors > As an investment
Revenio as an investment
The global eye care market is supported by powerful megatrends
Revenio is one of the leading turnkey solutions providers in the global eye care market. Our addressable market in ophthalmic diagnostic equipment is approximately USD 2.7 billion, with growth supported by powerful megatrends and changing industry dynamics. The need for eye care continues to increase globally as the population ages and as healthcare environments and lifestyles evolve. Chronic lifestyle-related diseases, such as diabetes, are becoming more common and increasing the strain on healthcare, especially in developed countries.
The growing need for eye care is outpacing the availability of skilled professionals in the field. To help address gaps in eye care capacity, optical retail and optometry are expanding their role in screening and diagnostics, expanding access to care. This shift means that intelligent eye care systems that improve efficiency, support clinical decision-making and enable earlier diagnosis are becoming increasingly important.
By enabling accurate refraction, efficient screening and earlier detection of eye diseases, Revenio addresses the critical challenges in eye care, supports the delivery of diagnostics across a broader range of eye care settings and improves the quality of life of people around the world.
A comprehensive offering to advance clinical confidence and workflow excellence
For decades, Revenio has combined clinical understanding, technological innovation and user-centric design to develop solutions for the early detection, diagnosis and monitoring of eye diseases. We concentrate innovation on ophthalmic diagnostics and clinical workflows where we can build a defensible competitive advantage. Our ability to develop market-leading products and solutions gives eye care professionals greater confidence that their diagnoses are correct and based on strong clinical evidence and reliable data.
We offer a comprehensive portfolio of solutions for eye health, helping diagnose multiple ophthalmic pathologies and serving eye care professionals in optical retail, optometry and ophthalmology. Our diagnostic devices include tonometers, fundus imaging devices, perimeters and microperimeters under the iCare brand. By joining forces with Visionix in 2026, we expanded our portfolio to include eye examination standard equipment, refraction systems, multimodal diagnostics, OCT and optical lab finishing equipment. The new broad portfolio is connected by our cloud-based platforms, enabling screening, remote solutions and leveraging AI, significantly broadening our ability to support the complete eye care workflow and patient journey.
We innovate to provide diagnostic confidence, connected solutions and workflows to enable earlier detection and intervention, advancing clinical decision-making across eye care settings. The competitive advantages of our portfolio are built on four cornerstones: efficiency, ease of use, clinical confidence and quality as well as innovation. These cornerstones are protected by patents, regulatory approvals and strong brands.
A scalable and efficient go-to-market model
With a presence in more than 130 countries, Revenio has built a global commercial platform combining long-standing distributor relationships with a well-established direct commercial organization in the United States. Joining forces with Visionix significantly strengthens this platform with complementary commercial capabilities and expanded direct market coverage through Visionix’s established sales organizations in Central and Southern Europe. Together with Visionix, we can unlock greater value from our distribution network through deeper long-term partnerships.
Our scalable, focused and capital-efficient go-to-market model provides extensive coverage of our targeted customer segments and close customer proximity, creating an effective foundation for launching new technologies and accelerating sustainable growth. The go-to-market model and broader product portfolio together enable us to reach new customers and markets, deepen existing customer relationships and capture a wider range of growth and cross-selling opportunities.
Operational excellence and quality, with people and culture as the foundation
We have made a significant journey from an equipment supplier to a global frontrunner in ophthalmic diagnostics, and joining forces with Visionix in 2026 marks the next phase in this evolution. We keep building a scalable and cost-efficient operating platform that combines our strengths across supply chain, service and support. This enables us to capture operational synergies and continuously improve efficiency while maintaining high quality and staying close to customers.
Quality and regulatory excellence remain fundamental to our success. We foster a culture of quality across the organization and all products, ensuring compliance, supporting market access and maintaining the trust of customers, patients and healthcare professionals worldwide.
Our people and culture are central to realizing the full potential of the organization. By bringing together complementary capabilities and expertise, building common ways of working and investing in our talent and leadership, we strengthen our ability to innovate and serve our customers worldwide.
Well positioned for growth and value creation
Revenio has proven its ability to grow profitably and sustainably for over a decade. After joining forces with Visionix, we are even better positioned to compete in the eye care market and accelerate growth and value creation with greater scale and broader capabilities.
We aim to deliver growth above the market through complementary drivers: expanding our customer and geographic reach, cross-selling the combined portfolio and developing new integrated solutions.
We are also committed to maintaining a strong focus on profitability and driving sustainable value creation. As the integration of Visionix progresses, operational efficiencies, scale benefits and operating model improvements are expected to support earnings, while targeted margin improvement initiatives across the combined operations are expected to drive further margin expansion.
Our financial priorities are clear: continued profitable growth, stronger cash generation and sustainable shareholder value.
Revenio Group Oyj | Härkähaankuja 7, 01730 Vantaa